Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

In this expert-led case study, learn more about:

✓ Prolonging remission in AML

✓ Recommendations for upfront therapy

✓ Selecting between various maintenance strategies

 

In this exclusive case study, hear from David Sallman, MD, Moffitt Cancer Center, Tampa, FL, who introduces a case featuring a 64-year-old male with acute myeloid leukemia (AML). Dr Sallman discusses first-line treatment approaches, consolidation, and options for maintenance therapy, with the overall goal of prolonging remission in this patient.

Prior to completing this activity, how would you rate your confidence in selecting between maintenance therapy approaches for patients with AML?

Following the completion of this activity, how would you rate your confidence in selecting between maintenance therapy approaches for patients with AML?
I intend to change my clinical practice as a result of this activity

This educational activity has received independent medical education support from Bristol Myers Squibb. This supporter has no influence over the production of the content.

Explore more on our ‘Spotlight On: Prolonging Remission in AML‘ feature.

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals